Cargando…

Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its Mechanism of signal transmission in vitro

Detalles Bibliográficos
Autores principales: Li, Shiyu, Liu, Shuting, Jiang, Zhenyou, Feng, Lixia, Gao, Yong, Chen, Youyu, Xu, Anding, Huang, Wenhua, Zhang, Nuofu, Sun, Hanxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921284/
https://www.ncbi.nlm.nih.gov/pubmed/33654055
http://dx.doi.org/10.1038/s41392-021-00516-4
_version_ 1783658435324149760
author Li, Shiyu
Liu, Shuting
Jiang, Zhenyou
Feng, Lixia
Gao, Yong
Chen, Youyu
Xu, Anding
Huang, Wenhua
Zhang, Nuofu
Sun, Hanxiao
author_facet Li, Shiyu
Liu, Shuting
Jiang, Zhenyou
Feng, Lixia
Gao, Yong
Chen, Youyu
Xu, Anding
Huang, Wenhua
Zhang, Nuofu
Sun, Hanxiao
author_sort Li, Shiyu
collection PubMed
description
format Online
Article
Text
id pubmed-7921284
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79212842021-03-02 Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its Mechanism of signal transmission in vitro Li, Shiyu Liu, Shuting Jiang, Zhenyou Feng, Lixia Gao, Yong Chen, Youyu Xu, Anding Huang, Wenhua Zhang, Nuofu Sun, Hanxiao Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-03-02 /pmc/articles/PMC7921284/ /pubmed/33654055 http://dx.doi.org/10.1038/s41392-021-00516-4 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Li, Shiyu
Liu, Shuting
Jiang, Zhenyou
Feng, Lixia
Gao, Yong
Chen, Youyu
Xu, Anding
Huang, Wenhua
Zhang, Nuofu
Sun, Hanxiao
Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its Mechanism of signal transmission in vitro
title Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its Mechanism of signal transmission in vitro
title_full Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its Mechanism of signal transmission in vitro
title_fullStr Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its Mechanism of signal transmission in vitro
title_full_unstemmed Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its Mechanism of signal transmission in vitro
title_short Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its Mechanism of signal transmission in vitro
title_sort study on the promotion of lymphocytes in patients with covid-19 by broad-spectrum chemokine receptor inhibitor vmip-ii and its mechanism of signal transmission in vitro
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921284/
https://www.ncbi.nlm.nih.gov/pubmed/33654055
http://dx.doi.org/10.1038/s41392-021-00516-4
work_keys_str_mv AT lishiyu studyonthepromotionoflymphocytesinpatientswithcovid19bybroadspectrumchemokinereceptorinhibitorvmipiianditsmechanismofsignaltransmissioninvitro
AT liushuting studyonthepromotionoflymphocytesinpatientswithcovid19bybroadspectrumchemokinereceptorinhibitorvmipiianditsmechanismofsignaltransmissioninvitro
AT jiangzhenyou studyonthepromotionoflymphocytesinpatientswithcovid19bybroadspectrumchemokinereceptorinhibitorvmipiianditsmechanismofsignaltransmissioninvitro
AT fenglixia studyonthepromotionoflymphocytesinpatientswithcovid19bybroadspectrumchemokinereceptorinhibitorvmipiianditsmechanismofsignaltransmissioninvitro
AT gaoyong studyonthepromotionoflymphocytesinpatientswithcovid19bybroadspectrumchemokinereceptorinhibitorvmipiianditsmechanismofsignaltransmissioninvitro
AT chenyouyu studyonthepromotionoflymphocytesinpatientswithcovid19bybroadspectrumchemokinereceptorinhibitorvmipiianditsmechanismofsignaltransmissioninvitro
AT xuanding studyonthepromotionoflymphocytesinpatientswithcovid19bybroadspectrumchemokinereceptorinhibitorvmipiianditsmechanismofsignaltransmissioninvitro
AT huangwenhua studyonthepromotionoflymphocytesinpatientswithcovid19bybroadspectrumchemokinereceptorinhibitorvmipiianditsmechanismofsignaltransmissioninvitro
AT zhangnuofu studyonthepromotionoflymphocytesinpatientswithcovid19bybroadspectrumchemokinereceptorinhibitorvmipiianditsmechanismofsignaltransmissioninvitro
AT sunhanxiao studyonthepromotionoflymphocytesinpatientswithcovid19bybroadspectrumchemokinereceptorinhibitorvmipiianditsmechanismofsignaltransmissioninvitro